FindTrial
Sign In

COMPARISON BETWEEN LEVOBUPIVACAINE PLUS DEXMEDETOMIDINE V/S LEVOBUPIVACAINE PLUS CLONIDINE IN TAP BLOCK FOR POSTOPERATIVE ANALGESIA FOLLOWING INGUINAL HERNIA REPAIR

COMPARISON OF DEXMEDETOMIDINE AND CLONIDINE AS AN ADJUVANT TO LEVOBUPIVACAINE IN TRANSVERSUS ABDOMINIS PLANE BLOCK FOR POSTOPERATIVE ANALGESIA FOLLOWING INGUINAL HERNIA REPAIR

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/05/033559
Enrollment
74
Registered
2021-05-12
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K409- Unilateral inguinal hernia, without obstruction or gangrene Health Condition 2: K409- Unilateral inguinal hernia, without obstruction or gangrene

Interventions

Intervention1: inj clonidine as an adjuvant to inj levobupivacaine: inj levobupivacaine 0.05% plus inj clonidine 1 mcg/kg Intervention2: inj dexmedetomidine as an adjuvant to inj. levobupivacaine: in

Sponsors

Dr Rashmi Thakur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Asa grade I & II age group 18-65 years height 140-170cm weight 30-90 kg BMI male patients who will be undrgoing elective, uncomplicated inguinal hernia reapir under subarachnoid block

Exclusion criteria

Exclusion criteria: 1.Refusal to enroll 2. Non-cooperative patients 3. Pre-existing abdominal pain. 4. Patients on analgesic drugs. 5. Duration of surgery >2 hours 6. Any intraoperative surgical complications. 7. Systemic disorders- liver, kidney, cardiac, respiratory, neurological, psychiatric disorders and bleeding tendencies. 8. Patients with history of allergic reactions to local anesthetics. 9. Presence of any contraindication to neuraxial anesthesia.

Design outcomes

Primary

MeasureTime frame
duration of analgesia with dexmedetomidine and clonidine as an adjuvant to levobupivacaine in TAP block.Timepoint: Within 24 hours—

Secondary

MeasureTime frame
Quality of pain relief as assessed by VAS. Total dose of rescue analgesic in 24 hours. Incidence of side effects(like sedation,nausea,vomiting, bradycardia,hypotension. Timepoint: within 24 hours—

Countries

India

Contacts

Public ContactDr Indresh Yadav

Dr. Bhimrao Ambedkar Memorial Hospital, Raipur

rash15nov@gmail.com9827485021

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026